1674-0440
2016 Issue 1
Genomics in Alzheimer′s disease
LEI Hong-xing;CAS Key Laboratory of Genome Science and Information;Beijing Institute of Genomics;Chinese Academy of Sciences;Cunji College of Medicine;University of Chinese Academy of Sciences;Center of Alzheimer′s Disease;Beijing Institute of Brain Disorders;
LEI Hong-xing;CAS Key Laboratory of Genome Science and Information;Beijing Institute of Genomics;Chinese Academy of Sciences;Cunji College of Medicine;University of Chinese Academy of Sciences;Center of Alzheimer′s Disease;Beijing Institute of Brain Disorders;
..............page:1-7
..............page:3
..............page:4
Advances in genome-wide association studies of sporadic Alzheimer′s disease
LU Rui;YANG Sheng-lian;WANG Yi-zheng;Institute of Neuroscience;Shanghai Institutes of Biological Science;Chinese Academy of Sciences;Research Center of Military Cognition and Brain Science;Academy of Military Medical Sciences;
LU Rui;YANG Sheng-lian;WANG Yi-zheng;Institute of Neuroscience;Shanghai Institutes of Biological Science;Chinese Academy of Sciences;Research Center of Military Cognition and Brain Science;Academy of Military Medical Sciences;
..............page:8-14
Gut microbiota and Alzheimer′s disease
LI Tong-ju;ZHAO Yang;DONG Guo-ming;JIA De-xian;MA Bai-ping;Ovation Health Science and Technology Co.Ltd.;ENN Group;Institute of Radiation Medicine;Academy of Military Medical Sciences;Beijing Hwellso Pharmaceutical Ltd.;
LI Tong-ju;ZHAO Yang;DONG Guo-ming;JIA De-xian;MA Bai-ping;Ovation Health Science and Technology Co.Ltd.;ENN Group;Institute of Radiation Medicine;Academy of Military Medical Sciences;Beijing Hwellso Pharmaceutical Ltd.;
..............page:15-19+32
Specific molecular probes in early diagnosis and efficacy monitoring for Alzheimer′s disease:research advances
HU Xiao;LI Lin;ZHANG Lan;Department of Pharmacology;Xuanwu Hospital of Capital Medical University;Beijing Institute for Brain Disorder;Beijing Engineering Research Center for Nervous System Drugs;Key Laboratory for Neurodegenerative Diseases of Ministry of Education;
HU Xiao;LI Lin;ZHANG Lan;Department of Pharmacology;Xuanwu Hospital of Capital Medical University;Beijing Institute for Brain Disorder;Beijing Engineering Research Center for Nervous System Drugs;Key Laboratory for Neurodegenerative Diseases of Ministry of Education;
..............page:20-25+49
Insulin signaling pathway and glucose metabolism in Alzheimer′s diseases
LI Dong;HUANG Yan;ZHOU Wen-xia;ZHANG Yong-xiang;Department of Traditional Medicine and Neuroimmunopharmacology;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
LI Dong;HUANG Yan;ZHOU Wen-xia;ZHANG Yong-xiang;Department of Traditional Medicine and Neuroimmunopharmacology;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:26-32
Important role of Rho/ROCK2 pathway in the development of Alzheimer′s disease
ZHANG Tian-bi;ZHANG Yun-long;HU Jing-wen;ZHANG Ying-jiu;Kay Laboratory for Matecular Enzymology and Engineering of the Millistry of Education;College of Life Scieuce;Jilin University;
ZHANG Tian-bi;ZHANG Yun-long;HU Jing-wen;ZHANG Ying-jiu;Kay Laboratory for Matecular Enzymology and Engineering of the Millistry of Education;College of Life Scieuce;Jilin University;
..............page:33-38
Activity regulation mechanisms of protein phosphatase 2A and its role in Alzheimer′s disease
LI Xue-lian;YANG Cui-cui;ZHANG Lan;Department of Pharmacology;Xuanwu Hospital;Capital Medical University;Key Laboratory for Basic Pharmacology of Ministry of Education;Zunyi Medical College;Beijing Engineering Research Center for Nervous System Drugs;Beijing Institute for Brain Disorders;Key Laboratory for Neurodegenerative Diseases of Ministry of Education;
LI Xue-lian;YANG Cui-cui;ZHANG Lan;Department of Pharmacology;Xuanwu Hospital;Capital Medical University;Key Laboratory for Basic Pharmacology of Ministry of Education;Zunyi Medical College;Beijing Engineering Research Center for Nervous System Drugs;Beijing Institute for Brain Disorders;Key Laboratory for Neurodegenerative Diseases of Ministry of Education;
..............page:39-43
Phosphodiesterase 4 as a target for the development of novel drugs against cognitive impairment:research advances
WANG Hai-tao;XU Jiang-ping;Department of Neuropharmacology and Novel Drug Discovery;School of Pharmaceutical Sciences;Southern Medical University;
WANG Hai-tao;XU Jiang-ping;Department of Neuropharmacology and Novel Drug Discovery;School of Pharmaceutical Sciences;Southern Medical University;
..............page:44-49
Contribution of luteinizing hormone to Alzheimer′s disease
WANG Jian-hui;CHENG Xiao-rui;ZHOU Wen-xia;ZHANG Yong-xiang;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Acadeny of Military Medical Sciences;
WANG Jian-hui;CHENG Xiao-rui;ZHOU Wen-xia;ZHANG Yong-xiang;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Acadeny of Military Medical Sciences;
..............page:50-55
Roles and functional changes of astrocytes in diabetic brain encephalopathy
SHI Si;WANG Xiao-liang;Institute of Materia Medica;Chinese Academy of Materia Medical Sciences & Peking Union Medical College;
SHI Si;WANG Xiao-liang;Institute of Materia Medica;Chinese Academy of Materia Medical Sciences & Peking Union Medical College;
..............page:56-61
BACE1 inhibitors:from peptide mimics to small molecules
LIU Jia-kuo;GU Wei;NIE Ai-hua;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
LIU Jia-kuo;GU Wei;NIE Ai-hua;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:62-78
Advances in novel anti-neurodegenerative diseases drugs targeting mitochondria
SUN Jing;GAO Jing;Mitochondrial & Neurobiology Laboratory;School of Pharmacy;Jiangsu University;
SUN Jing;GAO Jing;Mitochondrial & Neurobiology Laboratory;School of Pharmacy;Jiangsu University;
..............page:79-86
Advances in anti-Parkinson′s disease drugs and their related pharmacological targets
ZHANG Xue;ZHANG Wen;DU Li-da;GAO Li;DU Guan-hua;Beijing Key Laboratory of Drug Targets Identification and Drug Screening;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;School of Biomedical Science;the Chinese University of Hong Kong;Modern Research Center for Traditional Chinese Medicine;Shanxi University;
ZHANG Xue;ZHANG Wen;DU Li-da;GAO Li;DU Guan-hua;Beijing Key Laboratory of Drug Targets Identification and Drug Screening;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;School of Biomedical Science;the Chinese University of Hong Kong;Modern Research Center for Traditional Chinese Medicine;Shanxi University;
..............page:87-96
Leucine-rich repeat kinase 2 inhibitor as Parkinson′s disease novel therapeutics:research advances
ZHAN Xiao-yu;REN Xu-hong;HE Xin-hua;School of Pharmaceutical Engineering;Shenyang Pharmaceutical University;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
ZHAN Xiao-yu;REN Xu-hong;HE Xin-hua;School of Pharmaceutical Engineering;Shenyang Pharmaceutical University;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:97-103+133
Brain-targeted nasal drug delivery systems for the treatment of neurodegenerative diseases
DU Li-na;JIN Yi-guang;Institute of Radiation Medicine;Academy of Military Medical Sciences;
DU Li-na;JIN Yi-guang;Institute of Radiation Medicine;Academy of Military Medical Sciences;
..............page:104-109
Preparation of contingency plan of emergency medical response team for catastrophic chemical disasters
ZHAO Jian;DING Ri-gao;State Key Laboratory for Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
ZHAO Jian;DING Ri-gao;State Key Laboratory for Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:110-113
Deficienciesand developingrequirements ofmonitoring technology forchemical defense summarizing from“Tianjin Port 8·12 Explosion Accident”:a discussion
NIE Zhi-yong;WU Bi-dong;GUO Lei;CHEN Jia;YANG Zhi-kui;WANG Yong-an;XIE Jan-wei;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
NIE Zhi-yong;WU Bi-dong;GUO Lei;CHEN Jia;YANG Zhi-kui;WANG Yong-an;XIE Jan-wei;State Key Laboratory of Toxicology and Medical Countermeasures;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:114-120
Developing specific drug/device combination products improves the treatment level of the acute chemical injury
GAO Chun-sheng;ZHAO Jian;YANG Zhi-kui;ZHONG Wu;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
GAO Chun-sheng;ZHAO Jian;YANG Zhi-kui;ZHONG Wu;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:121-125
Advances in strategies to overcome the blood-brain barrier
ZHANG Min;ZHANG Jun-yu;ZHONG Wu;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;General Hospital of Tibet Military Command;
ZHANG Min;ZHANG Jun-yu;ZHONG Wu;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;General Hospital of Tibet Military Command;
..............page:126-133
Anti-hepatitis B virus drugs:research advances
WANG Hong-liang;LIU Xia-ling;CAO Shuang;Center for Drug Evaluation;China Food and Drug Administration;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
WANG Hong-liang;LIU Xia-ling;CAO Shuang;Center for Drug Evaluation;China Food and Drug Administration;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:134-138
kang ai bo la bing du hou xuan yi miao zai ji nei ya jin xing da gui mo lin chuang shi yan
huang shi jie ;
huang shi jie ;
..............page:138
Pathogenesis,prevention and treatment of high altitude pulmonary edema:research advances
JIANG Yan;WANG Lei-chen;WANG Jian-bo;Institute of Materia Medica;the Fourth Military Medical University;
JIANG Yan;WANG Lei-chen;WANG Jian-bo;Institute of Materia Medica;the Fourth Military Medical University;
..............page:139-145
gan jing yi dao su yu li xi na zuo gu ding bi li fu fang zhi liao 2 xing tang niao bing qi lin chuang shi yan da dao zhu zhong dian
huang shi jie ;
huang shi jie ;
..............page:145
Anti-oxidative stress actions and regulation mechanisms of Keap1-Nrf2/ARE signal pathway
HU Liu-fang;WANG Ying;REN Ru-jing;HUO Hai-ru;SUN Jian-hui;LI Hong-mei;ZHU Ya-ying;TAN Yu-qing;Center for Evaluation of Safety;Institute of Chinese Materia Medica;China Academyof Chinese Medical Sciences;
HU Liu-fang;WANG Ying;REN Ru-jing;HUO Hai-ru;SUN Jian-hui;LI Hong-mei;ZHU Ya-ying;TAN Yu-qing;Center for Evaluation of Safety;Institute of Chinese Materia Medica;China Academyof Chinese Medical Sciences;
..............page:146-152+166
Screening and identification of cell-penetrating peptides by display technology
SONG Yang;LIU Chang-bai;Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy;China Three Gorges University;
SONG Yang;LIU Chang-bai;Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy;China Three Gorges University;
..............page:153-156
Effects of detoxificating and stasis-removing herbal medicament on immune function in immunosuppressive mice
YANG Hai;GENG Chuan-xin;ZHAO Xia;ZHOU Xue-feng;ZOU Xiao;Key Laboratory of Marine Drugs;Ministry of Education;School of Medicine and Pharmacy;Ocean University of China;Qingdao Center Hospital;Qingdao Tumor Hospital;
YANG Hai;GENG Chuan-xin;ZHAO Xia;ZHOU Xue-feng;ZOU Xiao;Key Laboratory of Marine Drugs;Ministry of Education;School of Medicine and Pharmacy;Ocean University of China;Qingdao Center Hospital;Qingdao Tumor Hospital;
..............page:157-161
Development of LC-MS/MS method for rapid quantification of lopinavir/ritonavir(Kaletra)in human plasma
SHI Mei-hui;LI Jian;GAN Hui;ZHENG Ying;MENG Zhi-yun;DOU Gui-fang;Institute of Transfusion Medicine;Academy of Military Medical Sciences;
SHI Mei-hui;LI Jian;GAN Hui;ZHENG Ying;MENG Zhi-yun;DOU Gui-fang;Institute of Transfusion Medicine;Academy of Military Medical Sciences;
..............page:162-166
Overviews and analysis of the U.S. FDA′s new approvals in the 2015 second half year
TANG Zhong-ming;Institute of Radiation Medicine;Academy of Military Medical Sciences;
TANG Zhong-ming;Institute of Radiation Medicine;Academy of Military Medical Sciences;
..............page:167-178
..............page:178
zhen tong yao le pai si dan kang kai shi qi lin chuang shi yan
huang shi jie ;
huang shi jie ;
..............page:179
bi ni ti ni he en ke fei ni wu yong zhi liao hei se su liu
huang shi jie ;
huang shi jie ;
..............page:179
xin dan kang yao ba li ti ni zhi liao lei feng shi xing guan jie yan de liao xiao you yu jia an die zuo
huang shi jie ;
huang shi jie ;
..............page:179
yi nuo bo sha zhi liao ru xian ai
huang shi jie ;
huang shi jie ;
..............page:179
ao ke zhu dan kang zhi liao yuan fa xing duo fa xing ying hua qi lin chuang shi yan xian shi yang xing jie guo
huang shi jie ;
huang shi jie ;
..............page:179
..............page:180-182